The Serum LDH Level and KELIM Scores Are Potential Predictors of a Benefit from Bevacizumab First-Line Therapy for Patients with Advanced Ovarian Cancer
Clinical and Translational Oncology（2024）
Key words
Ovarian cancer,Bevacizumab,Biomarkers,LDH,KELIM
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined